Literature DB >> 15751579

Qualitative risk assessment of chronic renal failure development in healthy, female cats as based on the content of eicosapentaenoic acid in adipose tissue and that of arachidonic acid in plasma cholesteryl esters.

E A Plantinga1, R Hovenier, A C Beynen.   

Abstract

A study was carried out to assess the qualitative risk of development of chronic renal failure (CRF) in young healthy, female cats as based on the content of arachidonic acid (AA) in plasma cholesteryl esters (CE) and eicosapentaenoic acid (EPA) in adipose tissue. It has been suggested that the content of AA in CE should be <10% of total fatty acids (TFA) and of EPA in adipose tissue be >1.4% of TFA. Subcutaneous adipose tissue and blood samples were obtained from 48 female cats. There was a statistically significant correlation between linoleic acid content of adipose tissue and that of plasma CE. In all cats the EPA content of adipose tissue was lower than 1.4% of TFA and in 30 cats that of AA in plasma CE was higher than 10% of TFA. The EPA content of adipose tissue and the AA content of plasma CE are determined by the contents of these fatty acids in the diet. It is concluded that the fatty acid composition of cat foods should be determined and that, if deemed necessary, the ingredient composition should be altered so that the content of EPA is raised and that of AA is lowererd.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15751579     DOI: 10.1023/b:verc.0000048510.22459.89

Source DB:  PubMed          Journal:  Vet Res Commun        ISSN: 0165-7380            Impact factor:   2.459


  14 in total

1.  Relationship between the amount of linoleic acid in the diet and that in the adipose tissue of adult cats living freely in households.

Authors:  E A Plantinga; N Van Dijk; M H F Van Niel; A C Beynen
Journal:  Vet Res Commun       Date:  2003-12       Impact factor: 2.459

2.  Survival of cats with naturally occurring chronic renal failure: effect of dietary management.

Authors:  J Elliott; J M Rawlings; P J Markwell; P J Barber
Journal:  J Small Anim Pract       Date:  2000-06       Impact factor: 1.522

3.  Sources of variance in 24-hour dietary recall data: implications for nutrition study design and interpretation.

Authors:  G H Beaton; J Milner; P Corey; V McGuire; M Cousins; E Stewart; M de Ramos; D Hewitt; P V Grambsch; N Kassim; J A Little
Journal:  Am J Clin Nutr       Date:  1979-12       Impact factor: 7.045

4.  The intake of polyunsaturated fatty acids by cats is reflected in their adipose tissue.

Authors:  M H van Niel; A C Beynen
Journal:  Vet Q       Date:  1997-11       Impact factor: 3.320

5.  Specificity of lecithin:cholesterol acyltransferase and atherogenic risk: comparative studies on the plasma composition and in vitro synthesis of cholesteryl esters in 14 vertebrate species.

Authors:  M Liu; J D Bagdade; P V Subbaiah
Journal:  J Lipid Res       Date:  1995-08       Impact factor: 5.922

Review 6.  Synthetic substrates of lecithin: cholesterol acyltransferase.

Authors:  A Jonas
Journal:  J Lipid Res       Date:  1986-07       Impact factor: 5.922

7.  Gas-liquid chromatographic determination of fatty acid composition of cholesteryl esters in human serum using silica Sep-Pak cartridges.

Authors:  S T Wang; F Peter
Journal:  J Chromatogr       Date:  1983-09-09

8.  Relationship between the fatty acid composition of the diet and that of the subcutaneous adipose tissue in individual human subjects.

Authors:  T Plakké; J Berkel; A C Beynen; R J Hermus; M B Katan
Journal:  Hum Nutr Appl Nutr       Date:  1983-10

9.  The influence of dietary fish oil vs. sunflower oil on the fatty acid composition of plasma cholesteryl-esters in healthy, adult cats.

Authors:  E A Plantinga; A C Beynen
Journal:  J Anim Physiol Anim Nutr (Berl)       Date:  2003-12       Impact factor: 2.130

10.  Rapid separation of neutral lipids, free fatty acids and polar lipids using prepacked silica Sep-Pak columns.

Authors:  J G Hamilton; K Comai
Journal:  Lipids       Date:  1988-12       Impact factor: 1.880

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.